EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In Vivo Endothelial Cell Gene Silencing by siRNA‐LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting

Mina Yazdi, Jana Pöhmerer, Morteza Hasanzadeh Kafshgari, Johanna Seidl, Melina Grau, Miriam Höhn, Victoria Vetter, Cosima C Hoch, Barbara Wollenberg, Gabriele Multhoff, Ali Bashiri Dezfouli, Ernst Wagner iD

Small · 2024-10 · 20 (42)

DOI: 10.1002/smll.202400643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 25.06.2024. Verfasst von Mina Yazdi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität (LMU), 81377, Munich, Germany. Hauptthemen laut MEDLINE: RNA, Small Interfering, Gene Silencing, Nanoparticles, Endothelial Cells. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although small‐interfering RNAs (siRNAs) are specific silencers for numerous disease‐related genes, their clinical applications still require safe and effective means of delivery into target cells. Highly efficient lipid nanoparticles (LNPs) are developed for siRNA delivery, showcasing the advantages of novel pH‐responsive lipoamino xenopeptide (XP) carriers. These sequence‐defined XPs are assembled by branched lysine linkages between cationizable polar succinoyl tetraethylene pentamine (Stp) units and apolar lipoamino fatty acids (LAFs) at various ratios into bundle or U‐shape topologies. Formulation of siRNA‐LNPs using LAF 4 ‐Stp 1 XPs as ionizable compounds led to robust cellular uptake, high endosomal escape, and successful in vitro gene silencing activity at an extremely low (150 picogram) siRNA dose. Of significance is the functional in vivo endothelium tropism of siRNA‐LNPs with bundle LAF 4 ‐Stp 1 XP after intravenous injection into mice, demonstrated by superior knockdown of liver sinusoidal endothelial cell (LSEC)‐derived factor VIII (FVIII) and moderate silencing of hepatocyte‐derived FVII compared to DLin‐MC3‐DMA‐based LNPs. Optimizing lipid composition following click‐modification of siRNA‐LNPs with ligand c(RGDfK) efficiently silenced vascular endothelial growth factor receptor‐2 (VEGFR‐2) in tumor endothelial cells (TECs). The findings shed light on the role of ionizable XPs in the LNP in vivo cell‐type functional targeting, laying the groundwork for future therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingGene SilencingNanoparticlesEndothelial CellsAnimalsLigandsMiceLipidsHumansLiposomes

Stichwörter der Autor:innen

cRGDendothelial cellslipid nanoparticleslipoamino fatty acidliversiRNA deliverytargetingtumor

Substanzen

RNA, Small InterferingLigandsLipidsLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Pharmaceutical Biotechnology, Department of Pharmacy, Ludwig-Maximilians-Universität (LMU), 81377, Munich, Germany.
  • CNATM - Cluster for Nucleic Acid Therapeutics, 81377, Munich, Germany.
  • Central Institute for Translational Cancer Research (TranslaTUM), TUM School of Medicine and Health, Technical University of Munich (TUM), 81675, Munich, Germany.
  • Department of Radiation Oncology, TUM School of Medicine and Health, Technical University of Munich (TUM), 81675, Munich, Germany.
  • Department of Otorhinolaryngology, TUM School of Medicine and Health, Technical University of Munich (TUM), 81675, Munich, Germany.
  • Center for Nanoscience (CeNS), Ludwig-Maximilians-Universität (LMU), 80539, Munich, Germany.

ORCID-Profile: Ernst Wagner

Förderung

  • Bundesministerium für Bildung und Forschung
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Yazdi, M., Pöhmerer, J., Hasanzadeh Kafshgari, M., Seidl, J., Grau, M., Höhn, M., Vetter, V., Hoch, C. C., Wollenberg, B., Multhoff, G., Bashiri Dezfouli, A., & Wagner, E. (2024). In Vivo Endothelial Cell Gene Silencing by siRNA‐LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting. Small, 20(42). https://doi.org/10.1002/smll.202400643

Vancouver

Yazdi M, Pöhmerer J, Hasanzadeh Kafshgari M, Seidl J, Grau M, Höhn M, et al. In Vivo Endothelial Cell Gene Silencing by siRNA‐LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting. Small. 2024;20(42). doi:10.1002/smll.202400643

BibTeX
@article{Yazdi2024,
  author = {Yazdi, Mina and Pöhmerer, Jana and Hasanzadeh Kafshgari, Morteza and Seidl, Johanna and Grau, Melina and Höhn, Miriam and Vetter, Victoria and Hoch, Cosima C and Wollenberg, Barbara and Multhoff, Gabriele and Bashiri Dezfouli, Ali and Wagner, Ernst},
  title = {In Vivo Endothelial Cell Gene Silencing by siRNA‐LNPs Tuned with Lipoamino Bundle Chemical and Ligand Targeting},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {42},
  doi = {10.1002/smll.202400643}
}
Kostenlos starten →